Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FY23J
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,064
Award facts
- Contract value 100% obligated
- $15,063.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract, awarded on September 17, 2025, carries a ceiling value of $15,063.78 and operates under a firm fixed-price structure with an ultimate completion date of October 8, 2025. This delivery order was issued without set-aside designation, and the place of performance is the vendor's location in Park Ridge, Illinois.
This award represents a delivery order issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. EXPAREL is a long-acting local anesthetic used in surgical and medical procedures, and its procurement through the DLA's pharmaceutical supply chain supports the medical needs of Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical distribution network, leveraging its woman-owned small business status to compete effectively for contracts across a broad portfolio of pharmaceutical products serving military health systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FY23J?
SPE2DB25FY23J was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FY23J worth?
The government has obligated $15,064 on SPE2DB25FY23J.
Is contract SPE2DB25FY23J an order under another contract?
Yes. SPE2DB25FY23J is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY23J competed?
The extent of competition for SPE2DB25FY23J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award